title: Recent insights into the treatment of stable CAD : FFR-guided PCI vs. medical therapy.
abstract: Cornerstones in the treatment of coronary artery disease (CAD) are medical therapy and coronary revascularization. In acute settings (ST-elevation myocardial infarction and non-ST-elevation myocardial infarction), percutaneous coronary intervention (PCI) has proven to improve prognosis. The optimal treatment of stable CAD is subject to great controversy. By using fractional flow reserve to guide PCI, it is possible to stent only those lesions that induce myocardial ischemia. This review aims to reflect on the use of FFR-guided PCI in stable CAD.
authors.affiliation: Department of Cardiology, Catharina Hospital Eindhoven, Michelangelolaan 2, Eindhoven, The Netherlands.
authors.forename: L X
authors.initials: LX
authors.lastname: van Nunen
authors.forename: P A L
authors.initials: PA
authors.lastname: Tonino
mesh_terms: D002316:Cardiotonic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003324:Coronary Artery Disease / Q000175:diagnosis* / Q000628:therapy*; D019317:Evidence-Based Medicine; D053805:Fractional Flow Reserve, Myocardial; D006801:Humans; D062645:Percutaneous Coronary Intervention / Q000379:methods*; D025321:Surgery, Computer-Assisted / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D002316:Cardiotonic Agents